Results 211 to 220 of about 71,888 (256)

How Do Therapists Experience 20‐Session Cognitive‐Behavioral Therapy for Anorexia Nervosa (CBT‐AN‐20)? A Qualitative Study

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective We need to understand therapists' experiences of delivering manual‐based psychotherapies to identify possible dissemination barriers and opportunities. This study explored therapists' experiences of delivering CBT‐AN‐20, a new 20‐session cognitive‐behavioral intervention for outpatients with anorexia nervosa.
Heather C. Duggan   +8 more
wiley   +1 more source

Diagnostic Lag in Precision Medicine

open access: yes
Clinical Pharmacology &Therapeutics, EarlyView.
Petr Heneberg
wiley   +1 more source

Pragmatic Patient Engagement in Designing Pragmatic Oncology Clinical Trials

Future Oncology, 2021
Oncology trials are the cornerstone of effective and safe therapeutic discoveries. However, there is increasing demand for pragmatism and patient engagement in the design, implementation and dissemination of oncology trials. Many researchers are uncertain about making trials more practical and even less knowledgeable about how to meaningfully engage ...
Michelle Medeiros   +2 more
exaly   +3 more sources

Pragmatic Clinical Trials in Osteoporosis

Current Osteoporosis Reports, 2019
In this review, we present the application of pragmatic clinical trials for evaluating interventions in osteoporosis, and we discuss methodological considerations for designing and conducting a pragmatic clinical trial compared with a classical randomized clinical trial.Pragmatic clinical trials are a popular study design testing effectiveness of ...
Kenneth Saag   +2 more
exaly   +3 more sources

Clinical Trials Overview: From Explanatory to Pragmatic Clinical Trials

Mayo Clinic Proceedings, 2023
Clinical trials have been the bedrock of research to evaluate the safety and efficacy of new medical, surgical, or other interventions. Traditional "explanatory" clinical trials have aimed to explain a biological cause (new treatment) and effect (patient outcome) while controlling for many factors that might impact the evaluation, such as restricted ...
Jennifer Le-Rademacher   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy